IgE-based immunotherapy of cancer: challenges and chances

Passive immunotherapy with monoclonal antibodies is an indispensable cornerstone of clinical oncology. Notably, all FDA-approved antibodies comprise the IgG class, although numerous research articles proposed monoclonal antibodies of the IgM, IgG, IgA and IgE classes directed specifically against tu...

Descripción completa

Detalles Bibliográficos
Autores principales: Singer, J, Jensen-Jarolim, E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2014
Materias:
Review Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4022995/
https://www.ncbi.nlm.nih.gov/pubmed/24117861
http://dx.doi.org/10.1111/all.12276

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4022995/
https://www.ncbi.nlm.nih.gov/pubmed/24117861
http://dx.doi.org/10.1111/all.12276

Ejemplares similares